Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) CRISPR And CRISPR-Associated (Cas) Genes Market 2018, Forecast to 2023

Publisher Name :
Date: 10-Aug-2018
No. of pages: 136

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.

The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

Scope of the Report:

This report focuses on the CRISPR And CRISPR-Associated (Cas) Genes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology.

The worldwide market for CRISPR And CRISPR-Associated (Cas) Genes is expected to grow at a CAGR of roughly 39.8% over the next five years, will reach 2640 million US$ in 2023, from 350 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Caribou Biosciences

- Addgene

- CRISPR THERAPEUTICS

- Merck KGaA

- Mirus Bio LLC

- Editas Medicine

- Takara Bio USA

- Thermo Fisher Scientific

- Horizon Discovery Group

- Intellia Therapeutics

- GE Healthcare Dharmacon

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Genome Editing

- Genetic engineering

- gRNA Database/Gene Librar

- CRISPR Plasmid

- Human Stem Cells

- Genetically Modified Organisms/Crops

- Cell Line Engineering

Market Segment by Applications, can be divided into

- Biotechnology Companies

- Pharmaceutical Companies

- Academic Institutes

- Research and Development Institutes

There are 15 Chapters to deeply display the global CRISPR And CRISPR-Associated (Cas) Genes market.

Chapter 1, to describe CRISPR And CRISPR-Associated (Cas) Genes Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of CRISPR And CRISPR-Associated (Cas) Genes, with sales, revenue, and price of CRISPR And CRISPR-Associated (Cas) Genes, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of CRISPR And CRISPR-Associated (Cas) Genes, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, CRISPR And CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe CRISPR And CRISPR-Associated (Cas) Genes sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) CRISPR And CRISPR-Associated (Cas) Genes Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 CRISPR And CRISPR-Associated (Cas) Genes Introduction
1.2 Market Analysis by Type
1.2.1 Genome Editing
1.2.2 Genetic engineering
1.2.3 gRNA Database/Gene Librar
1.2.4 CRISPR Plasmid
1.2.5 Human Stem Cells
1.2.6 Genetically Modified Organisms/Crops
1.2.7 Cell Line Engineering
1.3 Market Analysis by Applications
1.3.1 Biotechnology Companies
1.3.2 Pharmaceutical Companies
1.3.3 Academic Institutes
1.3.4 Research and Development Institutes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Caribou Biosciences
2.1.1 Business Overview
2.1.1.1 Caribou Biosciences Description
2.1.1.2 Caribou Biosciences Headquarter, Main Business and Finance Overview
2.1.2 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.1.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.1.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.2 Addgene
2.2.1 Business Overview
2.2.1.1 Addgene Description
2.2.1.2 Addgene Headquarter, Main Business and Finance Overview
2.2.2 Addgene CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.2.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.2.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Addgene CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.3 CRISPR THERAPEUTICS
2.3.1 Business Overview
2.3.1.1 CRISPR THERAPEUTICS Description
2.3.1.2 CRISPR THERAPEUTICS Headquarter, Main Business and Finance Overview
2.3.2 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.3.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.3.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.4 Merck KGaA
2.4.1 Business Overview
2.4.1.1 Merck KGaA Description
2.4.1.2 Merck KGaA Headquarter, Main Business and Finance Overview
2.4.2 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.4.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.4.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.5 Mirus Bio LLC
2.5.1 Business Overview
2.5.1.1 Mirus Bio LLC Description
2.5.1.2 Mirus Bio LLC Headquarter, Main Business and Finance Overview
2.5.2 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.5.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.5.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.6 Editas Medicine
2.6.1 Business Overview
2.6.1.1 Editas Medicine Description
2.6.1.2 Editas Medicine Headquarter, Main Business and Finance Overview
2.6.2 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.6.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.6.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.7 Takara Bio USA
2.7.1 Business Overview
2.7.1.1 Takara Bio USA Description
2.7.1.2 Takara Bio USA Headquarter, Main Business and Finance Overview
2.7.2 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.7.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.7.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.8 Thermo Fisher Scientific
2.8.1 Business Overview
2.8.1.1 Thermo Fisher Scientific Description
2.8.1.2 Thermo Fisher Scientific Headquarter, Main Business and Finance Overview
2.8.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.8.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.8.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.9 Horizon Discovery Group
2.9.1 Business Overview
2.9.1.1 Horizon Discovery Group Description
2.9.1.2 Horizon Discovery Group Headquarter, Main Business and Finance Overview
2.9.2 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.9.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.9.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.10 Intellia Therapeutics
2.10.1 Business Overview
2.10.1.1 Intellia Therapeutics Description
2.10.1.2 Intellia Therapeutics Headquarter, Main Business and Finance Overview
2.10.2 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.10.2.1 CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
2.10.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Information
2.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Market Share in 2017
2.11 GE Healthcare Dharmacon
2.11.1 Business Overview
2.11.2 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Product Introduction
2.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Competition, by Manufacturer
3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Manufacturer (2016-2017)
3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share in 2017
3.4.2 Top 5 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Regions
4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Regions
4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Regions (2013-2018)
4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Regions (2013-2018)
4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2013-2018)
4.5 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2013-2018)
5 North America CRISPR And CRISPR-Associated (Cas) Genes by Countries, Type, Application and Manufacturers
5.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
5.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2013-2018)
5.1.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2013-2018)
5.1.3 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
5.1.4 Canada CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
5.1.5 Mexico CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
5.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers (2016-2017)
5.2.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers (2016-2017)
5.3 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Type (2013-2018)
5.3.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Type (2013-2018)
5.4 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Application (2013-2018)
5.4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Application (2013-2018)
6 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries, Type, Application and Manufacturers
6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
6.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2013-2018)
6.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2013-2018)
6.1.3 Germany CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
6.1.4 UK CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
6.1.5 France CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
6.1.6 Russia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
6.1.7 Italy CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
6.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers (2016-2017)
6.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers (2016-2017)
6.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Type (2013-2018)
6.3.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Type (2013-2018)
6.4 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Application (2013-2018)
6.4.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes by Countries, Type,

Application and Manufacturers
7.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2013-2018)
7.1.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2013-2018)
7.1.3 China CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
7.1.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
7.1.5 Korea CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
7.1.6 India CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Application (2013-2018)
8 South America CRISPR And CRISPR-Associated (Cas) Genes by Countries, Type, Application and Manufacturers
8.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
8.1.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2013-2018)
8.1.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2013-2018)
8.1.3 Brazil CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
8.1.4 Argentina CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
8.1.5 Colombia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
8.2 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers (2016-2017)
8.2.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers (2016-2017)
8.3 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Type (2013-2018)
8.3.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Type (2013-2018)
8.4 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Application (2013-2018)
8.4.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2013-2018)
9.1.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
9.1.4 UAE CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
9.1.5 Egypt CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
9.1.6 Nigeria CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
9.1.7 South Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue and Revenue Share by Application (2013-2018)
10 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Type
10.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Type (2013-2018)
10.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2013-2018)
10.2 Genome Editing Sales Growth and Price
10.2.1 Global Genome Editing Sales Growth (2013-2018)
10.2.2 Global Genome Editing Price (2013-2018)
10.3 Genetic engineering Sales Growth and Price
10.3.1 Global Genetic engineering Sales Growth (2013-2018)
10.3.2 Global Genetic engineering Price (2013-2018)
10.4 gRNA Database/Gene Librar Sales Growth and Price
10.4.1 Global gRNA Database/Gene Librar Sales Growth (2013-2018)
10.4.2 Global gRNA Database/Gene Librar Price (2013-2018)
10.5 CRISPR Plasmid Sales Growth and Price
10.5.1 Global CRISPR Plasmid Sales Growth (2013-2018)
10.5.2 Global CRISPR Plasmid Price (2013-2018)
10.6 Human Stem Cells Sales Growth and Price
10.6.1 Global Human Stem Cells Sales Growth (2013-2018)
10.6.2 Global Human Stem Cells Price (2013-2018)
10.7 Genetically Modified Organisms/Crops Sales Growth and Price
10.7.1 Global Genetically Modified Organisms/Crops Sales Growth (2013-2018)
10.7.2 Global Genetically Modified Organisms/Crops Price (2013-2018)
10.8 Cell Line Engineering Sales Growth and Price
10.8.1 Global Cell Line Engineering Sales Growth (2013-2018)
10.8.2 Global Cell Line Engineering Price (2013-2018)
11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Application
11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2013-2018)
11.2 Biotechnology Companies Sales Growth (2013-2018)
11.3 Pharmaceutical Companies Sales Growth (2013-2018)
11.4 Academic Institutes Sales Growth (2013-2018)
11.5 Research and Development Institutes Sales Growth (2013-2018)
12 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2018-2023)
12.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2018-2023)
12.2 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Regions (2018-2023)
12.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2018-2023)
12.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2018-2023)
12.2.3 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2018-2023)
12.2.4 South America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2018-2023)
12.2.5 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2018-2023)
12.3 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Type (2018-2023)
12.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2018-2023)
12.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2018-2023)
12.4 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Application (2018-2023)
12.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2018-2023)
12.4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure CRISPR And CRISPR-Associated (Cas) Genes Picture
Table Product Specifications of CRISPR And CRISPR-Associated (Cas) Genes
Figure Global CRISPR And CRISPR-Associated (Cas) Genes CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of CRISPR And CRISPR-Associated (Cas) Genes by Types in 2017
Figure Genome Editing Picture
Table Major Manufacturers of Genome Editing
Figure Genetic engineering Picture
Table Major Manufacturers of Genetic engineering
Figure gRNA Database/Gene Librar Picture
Table Major Manufacturers of gRNA Database/Gene Librar
Figure CRISPR Plasmid Picture
Table Major Manufacturers of CRISPR Plasmid
Figure Human Stem Cells Picture
Table Major Manufacturers of Human Stem Cells
Figure Genetically Modified Organisms/Crops Picture
Table Major Manufacturers of Genetically Modified Organisms/Crops
Figure Cell Line Engineering Picture
Table Major Manufacturers of Cell Line Engineering
Figure CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Applications in 2017
Figure Biotechnology Companies Picture
Figure Pharmaceutical Companies Picture
Figure Academic Institutes Picture
Figure Research and Development Institutes Picture
Figure United States CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Canada CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Germany CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure France CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure UK CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Russia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Italy CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure China CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Japan CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Korea CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure India CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2013-2023)
Table Caribou Biosciences Headquarter, Established, Main Business and Finance Overview (2017)
Table Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
Table Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product
Table Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share in 2017
Figure Global Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share in 2017
Table Addgene Headquarter, Established, Main Business and Finance Overview (2017)
Table Addgene CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
Table Addgene CRISPR And CRISPR-Associated (Cas) Genes Product
Table Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share in 2017
Figure Global Addgene CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share in 2017
Table CRISPR THERAPEUTICS Headquarter, Established, Main Business and Finance Overview (2017)
Table CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
Table CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Product
Table CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share in 2017
Figure Global CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share in 2017
Table Merck KGaA Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
Table Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Product
Table Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share in 2017
Figure Global Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share in 2017
Table Mirus Bio LLC Headquarter, Established, Main Business and Finance Overview (2017)
Table Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
Table Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Product
Table Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share in 2017
Figure Global Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share in 2017
Table Editas Medicine Headquarter, Established, Main Business and Finance Overview (2017)
Table Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Production Bases, Sales Regions and Major Competitors
Table Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product
Table Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figur
  • Global Compounding Pharmacy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 129
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients. Comp......
  • Global Human Prothrombin Complex Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. Scope of the Report: This report focuses on the Human Prothrombin Complex in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Human Prothrombin Complex Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 137
    Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. Scope of the Report: This report focuses on the Human Prothrombin Complex in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ......
  • Global Medical Rubber Stopper Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 145
    Medical Rubber Stopper is widely used for the pharmaceutical application which made from butyl rubber and are available in various sizes and styles depending on applications. Scope of the Report: This report focuses on the Medical Rubber Stopper in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The classification of Me......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Medical Rubber Stopper Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 145
    Medical Rubber Stopper is widely used for the pharmaceutical application which made from butyl rubber and are available in various sizes and styles depending on applications. Scope of the Report: This report focuses on the Medical Rubber Stopper in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The classification of Me......
  • Global Internal Nasal Dilators Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 128
    Internal Nasal Dilators are small devices that are made from plastic, or rubber. They fit directly into the nostril and remain in place all night to aid your breathing. The dilators are easy to insert and do not cause any undue discomfort when you have them inserted. Scope of the Report: This report focuses on the Internal Nasal Dilators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Internal Nasal Dilators Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 128
    Internal Nasal Dilators are small devices that are made from plastic, or rubber. They fit directly into the nostril and remain in place all night to aid your breathing. The dilators are easy to insert and do not cause any undue discomfort when you have them inserted. Scope of the Report: This report focuses on the Internal Nasal Dilators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the......
  • Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 129
    Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Self-Monitoring Blood Glucose (SMBG) Devices Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 131
    Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs